E20PC: Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures

Sponsor
Medtronic Cardiac Rhythm and Heart Failure (Industry)
Overall Status
Completed
CT.gov ID
NCT02326519
Collaborator
(none)
31
2
1
17.3
15.5
0.9

Study Details

Study Description

Brief Summary

Routine data collection will be conducted during normal sinus rhythm and AV synchronous pacing for approximately 20 minutes. The data collected will then be processed and the P, R and T wave amplitudes will be measured.

Condition or Disease Intervention/Treatment Phase
  • Other: Intracardiac electrode catheter
N/A

Detailed Description

The purpose of this study is to collect atrio-ventricular electrograms using a sequence of tip-ring spacings in patients undergoing routine cardiac procedures (EP study, pacemaker/ICD/CRT implant). To collect these signals, a 20 pole catheter (Medtronic StableMapr intracardiac steerable electrode catheter) will be acutely placed in the RV apex during a routine cardiac procedure.

Routine data collection will be conducted during normal sinus rhythm and AV synchronous pacing for approximately 20 minutes. The data collected will then be processed and the P, R and T wave amplitudes will be measured.

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures
Actual Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
Jan 13, 2015
Actual Study Completion Date :
Mar 13, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: Intracardiac electrode catheter

All patient in the study will have same data collected during the procedure using the Steerable intracardiac electrode catheter.

Other: Intracardiac electrode catheter
All patient in the study will have the same data collected using the Steerable intracardiac electrode catheter

Outcome Measures

Primary Outcome Measures

  1. The electrical signal mean amplitude (mv) during AV synchronous pacing. [2 minutes during the procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects aged 18 or above, or of legal age to give consent specific to the national law of the countries in which the study is being conducted

  • Subjects who are undergoing a cardiac procedure where routine placement of cardiac catheter can be performed

  • Subjects are willing to provide Informed Consent

Exclusion Criteria:
  • • Subject has exclusion criteria per local law and regulations (e.g. age, breast feeding, etc)

  • Any condition which precludes the subject's ability to comply with the study requirements

  • Subject has physical conditions that contraindicate the use of the device per approved labeling, including but not limited to active sepsis, known sensitivity to heparin, cannot undergo standard anticoagulation protocol for cardiac procedure, blood clotting abnormalities or a recent coagulopathy or embolic event, venous filtering device (Greenfield Filter) and obstructed or damaged vessel

Contacts and Locations

Locations

Site City State Country Postal Code
1 Allgemeines Krankenhaus der Stadt Linz Linz Austria
2 Hôpital Cardiologique du Haut-Lévêque Bordeaux France

Sponsors and Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medtronic Cardiac Rhythm and Heart Failure
ClinicalTrials.gov Identifier:
NCT02326519
Other Study ID Numbers:
  • E20PC study
First Posted:
Dec 29, 2014
Last Update Posted:
Dec 20, 2017
Last Verified:
Dec 1, 2017
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 20, 2017